Download
s13098-021-00700-0.pdf 615,51KB
WeightNameValue
1000 Titel
  • Metabolic control and hypoglycaemia in people with type 1 diabetes: insulin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care
1000 Autor/in
  1. Kramer, Guido |
  2. Kloos, Christof |
  3. Müller, Ulrich A. |
  4. Wolf, Gunter |
  5. Kuniss, Nadine |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-23
1000 Erschienen in
1000 Quellenangabe
  • 13(1):80
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13098-021-00700-0 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305953/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Aims!#!The aim of this study was to compare individuals with type 1 diabetes with continuous subcutaneous insulin infusion (CSII) and intensified insulin therapy (ICT) in routine care regarding metabolic control and treatment satisfaction.!##!Methods!#!Individuals with type 1 diabetes (CSII n = 74; ICT n = 163) were analysed regarding metabolic control, frequency of hypoglycaemia and treatment satisfaction (DTSQs range 0-36).!##!Results!#!Individuals with CSII (duration of CSII: 14.1 ± 7.2 years) were younger (51.1 ± 15.8 vs. 56.2 ± 16.2 years, p = 0.023), had longer diabetes duration (28.7 ± 12.4 vs. 24.6 ± 14.3 years, p = 0.033), lower insulin dosage (0.6 ± 0.2 vs. 0.7 ± 0.4 IU/kg, p = 0.004), used more frequently short-acting analogue insulin (90.5% vs. 48.5%, p < 0.001) and flash/continuous glucose monitoring (50.0% vs. 31.9%, p = 0.009) than people with ICT. HbA1c was similar between CSII and ICT (7.1 ± 0.8%/54.4 ± 9.1 mmol/mol vs. 7.2 ± 1.0%/55.7 ± 10.9 mmol/mol, p = 0.353). Individuals with CSII had higher frequency of non-severe hypoglycaemia per week (in people with blood glucose monitoring: 1.9 ± 1.7 vs. 1.2 ± 1.6, p = 0.014; in people with flash/continuous glucose monitoring: 3.3 ± 2.2 vs. 2.1 ± 2.0, p = 0.006). Prevalence of polyneuropathy (18.9% vs. 38.0%, p = 0.004) and systolic blood pressure (138.0 ± 16.4 vs. 143.9 ± 17.1 mmHg, p = 0.014) was lower in CSII. Satisfaction with diabetes treatment (26.7 ± 7.3 vs. 26.0 ± 6.8, p = 0.600) did not differ between CSII and ICT.!##!Conclusions!#!CSII and ICT yielded comparable metabolic control and treatment satisfaction but CSII was associated with higher incidence of non-severe hypoglycaemia and lower insulin dosage.
1000 Sacherschließung
lokal Continuous subcutaneous insulin infusion
lokal Insulin pump therapy
lokal Research
lokal Type 1 diabetes
lokal Intensified insulin therapy
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/S3JhbWVyLCBHdWlkbw==|https://frl.publisso.de/adhoc/uri/S2xvb3MsIENocmlzdG9m|https://frl.publisso.de/adhoc/uri/TcO8bGxlciwgVWxyaWNoIEEu|https://frl.publisso.de/adhoc/uri/V29sZiwgR3VudGVy|https://orcid.org/0000-0002-6744-1818
1000 Hinweis
  • DeepGreen-ID: 341cd6c9f7df4eff8b844abb5024e000 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6465986.rdf
1000 Erstellt am 2023-11-16T17:52:47.088+0100
1000 Erstellt von 322
1000 beschreibt frl:6465986
1000 Zuletzt bearbeitet 2023-12-01T03:28:26.358+0100
1000 Objekt bearb. Fri Dec 01 03:28:26 CET 2023
1000 Vgl. frl:6465986
1000 Oai Id
  1. oai:frl.publisso.de:frl:6465986 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source